💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Fate Therapeutics, Inc. (FATE)
« Back to company indexFATE Chatter Timeline
Stock Ticker for FATE
Most Active Tweeters for FATE
| User | Tweets |
|---|---|
| @stockmktgenius | 8 |
| @Gambiste1 | 8 |
| @PersimmonTI | 7 |
| @YuZhu4 | 7 |
| @JRMKE3 | 7 |
Recent Tweets for FATE
 |
@stockmktgenius $FATE Fate Therapeutics, Inc. - Top stock up 579% from low. Close: 114.31 VolvsAvg: 0.58 Liq: $95M https://t.co/MDvZ4cvDIr January 20th 2021, 4:01am |
 |
@BreyTristyn @jason_hotel $fate @jason_hotel January 20th 2021, 4:01am |
 |
@Fishbulb77 @CryptoCobain $fate $hate January 19th 2021, 1:01pm |
 |
@bti_trading RT @bti_trading: $FATE H6 Join the winning team and make 3-4 figures a day with our stocks signals. We cover all asset classes and many tim… January 19th 2021, 5:01am |
|
@bti_trading $FATE H6 Join the winning team and make 3-4 figures a day with our stocks signals. We cover all asset classes and m… https://t.co/chIj3KmnPV January 18th 2021, 5:01pm |
 |
@xZ0nic Notable insider buying last week - mainly from offerings $FATE - Redmile Group, LLC (10% owner) bought 327,485 sh… https://t.co/d85kMvWRaD January 18th 2021, 4:01am |
 |
@invest2rise RT @LuoshengPeng: Add $FATE to the GENE EDITING - CRISPR CAS9 grp. January 17th 2021, 12:01pm |
 |
@Biotech2k1 @alexei_lyvin $FATE was #1 for 3 years, but not at this bubbly valuation. January 17th 2021, 12:01pm |
 |
@dhovekamp42 @Slambucket Yes, this is the $ADAP and $FATE approach to true off-the-shelf cell therapies vs. donor derived alloge… https://t.co/GLyY3XtaG4 January 17th 2021, 10:01am |
 |
@wh3atth1nz @scottjo88508204 $FATE tried for new highs but couldn't hold. Keep your eye on it here to build out this consolidat… https://t.co/eJu23P1V0b January 16th 2021, 11:01pm |
 |
@PathSasikumar @nhawk45 @LuoshengPeng $FATE is targeting most profitable market. But most of the cancers are multi cell mutations… https://t.co/PwuqDVfveI January 16th 2021, 8:01pm |
 |
@intratio $FATE https://t.co/iNRgS2qUZ2 Fate Therapeutics Inc The model has predicted that this stock price has an unfavorabl… https://t.co/b5F0eWG2Xq January 16th 2021, 7:01pm |
 |
@nhawk45 @Zen_Options Are you familiar with or hearing any positive sentiment on $FATE. This went under my radar...looking to start a long position. January 16th 2021, 7:01pm |
|
@nhawk45 @PathSasikumar @LuoshengPeng but is $FATE doing anything different with their iPSC/NK platform than $EDIT, for exam… https://t.co/KTwWRLYfG1 January 16th 2021, 7:01pm |
 |
@LuoshengPeng Add $FATE to the GENE EDITING - CRISPR CAS9 grp. January 16th 2021, 7:01pm |
 |
@YuZhu4 RT @Biotech2k1: @lblegend33 I did that just this week. Last week I sold all the bubbly stocks that were trading at 4x value like $FATE. Thi… January 16th 2021, 4:01pm |
|
@nhawk45 @hiddensmallcaps Learning more and more about $FATE using CRISPR to engineer endogenous cells to fight cancer. Mark… https://t.co/GfKBxUSjrR January 16th 2021, 3:01pm |
|
@nhawk45 @LuoshengPeng Starting to learn more about $FATE engineering cells to fight cancer with CRISPR. Curious why more pe… https://t.co/zHAsaB0jmN January 16th 2021, 3:01pm |
 |
@rolf_widerhofer @LuoshengPeng Do not forget $FATE is using Crispr gene editing https://t.co/DRDyaeGVtw January 16th 2021, 9:01am |
|
@stockmktgenius $FATE Fate Therapeutics, Inc. - Top stock up 579% from low. Close: 113.59 VolvsAvg: 0.56 Liq: $93M https://t.co/MDvZ4cvDIr January 16th 2021, 12:01am |
 |
@QuantchaIdeas 52-Week High Alert: Trading today’s movement in FATE THERAPEUTICS INC. COMMON $FATE https://t.co/1ZRMymap21 January 15th 2021, 6:01pm |
 |
@mediasentiment $FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 314 January 15th 2021, 2:01pm |
 |
@TrdngDrivatives RT @mediasentiment: $FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 70 January 15th 2021, 10:01am |
|
@mediasentiment $FATE new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 70 January 15th 2021, 10:01am |
 |
@WatchlistN Fate Therapeutics, Inc. $FATE General Counsel Cindy Tahl Sells 9,483 Shares https://t.co/iwuWMkHKX5 January 15th 2021, 9:01am |
|
@stockmktgenius $FATE Fate Therapeutics, Inc. - Top stock up 579% from low. Close: 117.40 VolvsAvg: 0.50 Liq: $85M https://t.co/MDvZ4cvDIr January 15th 2021, 4:01am |
 |
@kwhenfinance Fate Therapeutics Inc. Shares Climb 0.2% Past Previous 52-Week High - Market Mover https://t.co/2fPyTwPrD8 $FATE #stockmarket #kwhenfinance January 15th 2021, 4:01am |
 |
@JRMKE3 [email protected]? Here you go! $FATE https://t.co/yAhmXA58iD January 15th 2021, 12:01am |
|
@JRMKE3 @Biotech2k1 Describe “crash” as it relates to $FATE! January 14th 2021, 10:01pm |
|
@JRMKE3 @Biotech2k1 @koko_vivian No doubt there will be a pullback in $FATE but I would question anyone saying it is in a b… https://t.co/pMs4buRyOW January 14th 2021, 8:01pm |
|
@Biotech2k1 @koko_vivian There really isn't anything left in cell therapies that isn't vastly overvalued due to the $FATE NK an… https://t.co/STWxkZ80uI January 14th 2021, 8:01pm |
 |
@TradeWithPVT $CRSP blasting off today... $FATE hasn't moved much. https://t.co/4ljznr1xMx January 14th 2021, 6:01pm |
 |
@elwalvador How about that $CRSP and $FATE today? huge huge winners. CRISPIFY everything. January 14th 2021, 5:01pm |
 |
@TamirTiko2110 @CasualtyWar very familiar to this....just today $unfi $fate ... I try to act as a robot as much as i can ..talk to… https://t.co/DSInU2ec8R January 14th 2021, 4:01pm |
 |
@ValueTrader101 $ADAP CEO discussion about other companies including $FATE and saying thy're also very competitive.. January 14th 2021, 4:01pm |
|
@BioEqman $FATE $11B valuation for 5 pt data.. lol. January 14th 2021, 4:01pm |
|
@TamirTiko2110 $FATE Daily update ???? Check below history #TechnicalAnalysis #StocksToTrade #StockMarket #stockstowatch… https://t.co/fy1DM5cxWY January 14th 2021, 3:01pm |
 |
@chiktrader1 $FATE, when does the short squeeze start ?? January 14th 2021, 3:01pm |
|
@intratio $FATE https://t.co/iNRgS2IvQA Fate Therapeutics Inc Our AI has forecasted this stock s value is in line with fundam… https://t.co/GHZLxID1BH January 14th 2021, 3:01pm |
|
@TamirTiko2110 $FATE Daily #LONGIDEA Break out Check below history #TechnicalAnalysis #StocksToTrade #StockMarket… https://t.co/3SBQKM8E1v January 14th 2021, 2:01pm |
 |
@Gambiste1 RT @PersimmonTI: $FATE Not only is Redmile Group the owner of more than 14% of $FATE outstanding equity, Redmile is also purchaser of a… January 14th 2021, 1:01pm |
 |
@PersimmonTI $FATE Not only is Redmile Group the owner of more than 14% of $FATE outstanding equity, Redmile is also purchas… https://t.co/etpIKL0Fel January 14th 2021, 1:01pm |
 |
@xIronman777 RT @TamirTiko2110: $FATE Daily #LONGIDEA B/O above Triangle measured move 154 Levels on chart #TechnicalAnalysis #StocksToTrade #St… January 14th 2021, 7:01am |
|
@TamirTiko2110 $FATE Daily #LONGIDEA B/O above Triangle measured move 154 Levels on chart #TechnicalAnalysis… https://t.co/lILabMkrTC January 14th 2021, 6:01am |
|
@stockmktgenius $FATE Fate Therapeutics, Inc. - Top stock up 578% from low. Close: 113.29 VolvsAvg: 0.62 Liq: $100M https://t.co/MDvZ4cvDIr January 14th 2021, 4:01am |
|
@wh3atth1nz @scottjo88508204 $FATE had a monster run in 2020 and possibly setting up for higher. Really nice accumulation volum… https://t.co/iPZZfvPkkZ January 14th 2021, 2:01am |
 |
@princetongb @OJRenick Stick to your $FATE January 14th 2021, 12:01am |
|
@TradeWithPVT $CRSP & $FATE are two stocks that have run up quite a bit over the past few months in an increasingly parabolic fas… https://t.co/CVMlsYfZhe January 14th 2021, 12:01am |
|
@PersimmonTI $FATE Some interesting goings-on with the insider filings of Redmile Group... ? https://t.co/qWkJc1cBGk January 13th 2021, 11:01pm |
 |
@rechraum @PersimmonTI $FATE That stake would be like 15% of their aum... ? January 13th 2021, 10:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
